467 related articles for article (PubMed ID: 30923193)
1. T cell stemness and dysfunction in tumors are triggered by a common mechanism.
Vodnala SK; Eil R; Kishton RJ; Sukumar M; Yamamoto TN; Ha NH; Lee PH; Shin M; Patel SJ; Yu Z; Palmer DC; Kruhlak MJ; Liu X; Locasale JW; Huang J; Roychoudhuri R; Finkel T; Klebanoff CA; Restifo NP
Science; 2019 Mar; 363(6434):. PubMed ID: 30923193
[TBL] [Abstract][Full Text] [Related]
2. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Carmona-Rodríguez L; Martínez-Rey D; Fernández-Aceñero MJ; González-Martín A; Paz-Cabezas M; Rodríguez-Rodríguez N; Pérez-Villamil B; Sáez ME; Díaz-Rubio E; Mira E; Mañes S
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591431
[TBL] [Abstract][Full Text] [Related]
3. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Control of Epigenetics and Its Role in CD8
Yerinde C; Siegmund B; Glauben R; Weidinger C
Front Immunol; 2019; 10():2718. PubMed ID: 31849941
[TBL] [Abstract][Full Text] [Related]
6. Potassium channels of T lymphocytes take center stage in the fight against cancer.
Conforti L
J Immunother Cancer; 2017; 5():2. PubMed ID: 28105369
[TBL] [Abstract][Full Text] [Related]
7. The aged tumor microenvironment limits T cell control of cancer.
Chen ACY; Jaiswal S; Martinez D; Yerinde C; Ji K; Miranda V; Fung ME; Weiss SA; Zschummel M; Taguchi K; Garris CS; Mempel TR; Hacohen N; Sen DR
Nat Immunol; 2024 Jun; 25(6):1033-1045. PubMed ID: 38745085
[TBL] [Abstract][Full Text] [Related]
8. Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.
Bellavance EC; Kohlhapp FJ; Zloza A; O'Sullivan JA; McCracken J; Jagoda MC; Lacek AT; Posner MC; Guevara-Patino JA
J Immunol; 2011 Mar; 186(6):3309-16. PubMed ID: 21289306
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen.
Vardhana SA; Hwee MA; Berisa M; Wells DK; Yost KE; King B; Smith M; Herrera PS; Chang HY; Satpathy AT; van den Brink MRM; Cross JR; Thompson CB
Nat Immunol; 2020 Sep; 21(9):1022-1033. PubMed ID: 32661364
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and exhaustion: defining mechanisms of T cell dysfunction.
Schietinger A; Greenberg PD
Trends Immunol; 2014 Feb; 35(2):51-60. PubMed ID: 24210163
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
[TBL] [Abstract][Full Text] [Related]
12. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
[TBL] [Abstract][Full Text] [Related]
13. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Jansen CS; Prokhnevska N; Master VA; Sanda MG; Carlisle JW; Bilen MA; Cardenas M; Wilkinson S; Lake R; Sowalsky AG; Valanparambil RM; Hudson WH; McGuire D; Melnick K; Khan AI; Kim K; Chang YM; Kim A; Filson CP; Alemozaffar M; Osunkoya AO; Mullane P; Ellis C; Akondy R; Im SJ; Kamphorst AO; Reyes A; Liu Y; Kissick H
Nature; 2019 Dec; 576(7787):465-470. PubMed ID: 31827286
[TBL] [Abstract][Full Text] [Related]
14. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
Reiser J; Banerjee A
J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
[TBL] [Abstract][Full Text] [Related]
15. IL-36β Promotes CD8
Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
Front Immunol; 2019; 10():1803. PubMed ID: 31447838
[TBL] [Abstract][Full Text] [Related]
16. Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment.
Arina A; Corrales L; Bronte V
Semin Immunol; 2016 Feb; 28(1):54-63. PubMed ID: 26872631
[TBL] [Abstract][Full Text] [Related]
17. T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.
Li G; Yang Q; Zhu Y; Wang HR; Chen X; Zhang X; Lu B
PLoS One; 2013; 8(6):e67401. PubMed ID: 23826287
[TBL] [Abstract][Full Text] [Related]
18. CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.
Le DT; Ladle BH; Lee T; Weiss V; Yao X; Leubner A; Armstrong TD; Jaffee EM
Int J Cancer; 2011 Aug; 129(3):636-47. PubMed ID: 20857491
[TBL] [Abstract][Full Text] [Related]
19. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8
Li J; He Y; Hao J; Ni L; Dong C
Front Immunol; 2018; 9():2981. PubMed ID: 30619337
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
